Bosulif 00069-0504
Generic: Bosutinib
Product NDC
00069-0504- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- January 2, 2024
- Listing Expires
- December 31, 2027
- Application
- NDA217729
Need to source Bosulif? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bosutinib Monohydrate | 50 mg/1 |
Drug Class
Bcr-Abl Tyrosine Kinase Inhibitors [MoA]Kinase Inhibitor [EPC]
Packaging Options(1)
30 CAPSULE in 1 BOTTLE (0069-0504-30)